Screener
Capricor Therapeutics CAPR Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| REVENUE / TOTAL REVENUE | Three Months Ended March 31, 2026 / — | Three Months Ended March 31, 2025 / — |
|---|---|---|
| LOSS FROM OPERATIONS | (36,772,853) | (24,982,948) |
| OTHER INCOME (EXPENSE) | ||
| Other income | 8,145 | 12,485 |
| Investment income | 2,904,506 | 729,542 |
| Loss on disposal of fixed assets | (81,143) | (150,673) |
| TOTAL OTHER INCOME (EXPENSE) | 2,831,508 | 591,354 |
| LOSS BEFORE INCOME TAXES | (33,941,345) | (24,391,594) |
| (Provision for) benefit from income taxes | — | — |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's interest income?
- Capricor Therapeutics (CAPR) reported interest income of $2.9M in Q1 2026.
- How has Capricor Therapeutics's interest income changed year-over-year?
- Capricor Therapeutics's interest income increased by 298.1% year-over-year, from $729.54K to $2.9M.
- What is the long-term trend for Capricor Therapeutics's interest income?
- Over 4 years (2021 to 2025), Capricor Therapeutics's interest income has grown at a 223.0% compound annual growth rate (CAGR), from $57.46K to $6.26M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Capricor Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude